Ledger.Open graph →
SEC Form D · filed April 5, 2018

Eleven Biotherapeutics, Inc

Offering
$996K
Sold
$996K
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CAMBRIDGE, MA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (21)

Jane V. Henderson · Cambridge, MADirectorWendy L. Dixon · Cambridge, MADirectorPaul G. Chaney · Cambridge, MADirectorAbbie C. Celniker · Cambridge, MADirectorDaniel S. Lynch · Cambridge, MADirectorBarry J. Gertz · Cambridge, MADirectorRichard F. Fitzgerald · Cambridge, MAExecLeslie G. Dan · Cambridge, MADirectorStephen A. Hurly · Cambridge, MAExec · DirectorJay S. Duker · Cambridge, MADirectorDaniel S. Lynch · Cambridge, MADirectorBarry J. Gertz · Cambridge, MADirectorRichard F. Fitzgerald · Cambridge, MAExecLeslie G. Dan · Cambridge, MADirectorJane V. Henderson · Cambridge, MADirectorWendy L. Dixon · Cambridge, MADirectorPaul G. Chaney · Cambridge, MADirectorStephen A. Hurly · Cambridge, MAExec · DirectorAbbie C. Celniker · Cambridge, MADirectorJay S. Duker · Cambridge, MADirectorDaniel S. Lynch · Stamford, CTDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗